Which statement about biosimilars is accurate?

• A. They are drugs produced in living cells
• B. They are small-molecule generics
• C. They do not require regulatory approval
• D. They are identical to brand labeling in all respects

Answer: (A)

Biosimilars are drugs produced in living cells, which reflects their biologic nature. Biologics are large, complex molecules made by living systems, so even though a biosimilar is designed to be highly similar to the reference product, it is not an exact copy. This is why they are not considered small-molecule generics, which are chemically identical copies of simple compounds. Biosimilars do require regulatory approval to demonstrate no clinically meaningful differences in safety, purity, and potency compared with the reference product. They are not guaranteed to be identical to brand labeling in all respects, since labeling and approved indications can differ based on regulatory decisions and post-market updates.